Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

1(50.0%)

N/A

1(50.0%)

2Total

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03794362Recruiting

Measuring Analgesic Interventions

Role: lead

NCT03605966Active Not Recruiting

Developing a Method to Objectively Measure Opioid Analgesia

Role: lead

NCT03596489Completed

Objective Assessment of Sensory Nerve Fiber Sensitivity

Role: lead

NCT03006718Not ApplicableCompleted

SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain

Role: lead

NCT02242058Completed

QST-Pupillometry in Sickle Cell Disease Patients

Role: lead

NCT02325284Completed

Objective Measurement of Pain Using the Algometer

Role: lead

NCT01325493Phase 4Completed

Low Dose Ketamine Study on Opioid Tolerance and Hyperalgesia

Role: lead

All 7 trials loaded